---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-053412"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2026-08-05T20:33:00+00:00"
generated_at: "2026-08-05T20:34:32.169207+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STERIS Q1 revenue $1.5B (+7%), adj EPS $2.59; announces $55-70M restructuring plan

## Summary
- Revenue $1.5B (+7% YoY); constant currency organic growth 6%. Adjusted EPS $2.59 vs $2.34 prior year.
- Healthcare segment revenue $1.05B (+8%); AST $297.6M (+6%); Life Sciences $146.7M (+9%).
- Operating cash flow $367.1M (down from $420M); free cash flow $279.6M (down from $326.5M).
- Restructuring: consolidation of chemistries to NC Center of Excellence; closure of St. Louis and Plymouth facilities; pre-tax charges $55-70M, completion by fiscal 2030.
- FY2027 guidance reaffirmed: revenue growth 7-8%, adj EPS $11.10-$11.30; CapEx raised to ~$450M, FCF now ~$800M.

## SEC filing metadata
- accession: 0001628280-26-053412
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2026-08-05T20:33:00+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/0001628280-26-053412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/ste-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-053412
- JSON: https://secwatch.observer/filing/0001628280-26-053412.json
- Plain text: https://secwatch.observer/filing/0001628280-26-053412.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.